In:
Personalized Medicine, Future Medicine Ltd, Vol. 9, No. 4 ( 2012-06), p. 429-439
Kurzfassung:
Personalized genomic medicine (PGM) is a goal that currently unites a wide array of biomedical initiatives, and is promoted as a ‘new paradigm for healthcare’ by its champions. Its promissory virtues include individualized diagnosis and risk prediction, more effective prevention and health promotion, and patient empowerment. Beyond overcoming scientific and technological hurdles to realizing PGM, proponents may interpret and rank these promises differently, which carries ethical and social implications for the realization of PGM as an approach to healthcare. We examine competing visions of PGM’s virtues and the directions in which they could take the field, in order to anticipate policy choices that may lie ahead for researchers, healthcare providers and the public.
Materialart:
Online-Ressource
ISSN:
1741-0541
,
1744-828X
Sprache:
Englisch
Verlag:
Future Medicine Ltd
Publikationsdatum:
2012
SSG:
15,3
Permalink